Impact of hypertension on short-and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes

Heart and Vessels

Volumn 27, Issue 4, 2012, Pages 370-376

  Lazzeri, Chiara ^a   Valente, Serafina ^a   Chiostri, Marco ^a   Attanà, Paola ^a   Picariello, Claudio ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute glucose dysmetabolism; Hypertension; Nondiabetic; Prognosis; ST elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STRESS;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CORONARY CARE UNITS; DIABETES MELLITUS; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; HYPERTENSION; INSULIN RESISTANCE; ITALY; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864277593     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-011-0169-6     Document Type: Article

References (32)

1. Dzau VJ (1990) Atherosclerosis and hypertension: mechanisms and interrelationships. J Cardiovasc Pharmacol 15(suppl 5):S59-S64 (Pubitemid 20159138)
2. Lin JF, Hsu SY, Wu S, Liau CS, Chang HC, Liu CJ, Huang HL, Ho YT, Weng SL, Ko YL (2011) Data feedback reduces door-toballoon time in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Heart Vessels 26:25-30
3. Feng Y, Shen C, Ma G, Wang J, Chen Z, Dai Q, Zhi H, Yang C, Fu Q, Shang G, Guan Y (2010) Prolonged pain to hospital time is associated with increased plasma advanced oxidation protein products and poor prognosis in patients with percutaneous coronary intervention for ST-elevation myocardial infarction. Heart Vessels 25(5):374-378
4. Lewington S, Clarke R, Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration (2002) Agespecific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903-1913 (Pubitemid 35472129)
5. Levy D, Wilson PW, Anderson KM, Castelli WP (1990) Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J 119(3 pt 2):712-717 (Pubitemid 20102989)
6. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937-952 (Pubitemid 39208455)
7. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM (1995) Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41, 021 patients. GUSTO-I Investigators. Circulation 91:1659-1668
8. Frazier CG, Shah SH, Armstrong PW, Bhapkar MV, McGuire DK, Sadowski Z, Kristinsson A, Aylward PE, Klein WW, Weaver WD, Newby LK, SYMPHONY and the Second SYMPHONY Investigators (2005) Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban Versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Postacute Coronary Syndromes (SYMPHONY) randomized clinical trials. Am Heart J 150:1260-1267 (Pubitemid 41781966)
9. Rabkin SW, Mathewson FAL, Tate RB (1977) Prognosis after acute myocardial infarction: relation to blood pressure values before infarction in a prospective cardiovascular study. Am J Cardiol 40(4):604-610 (Pubitemid 8219312)
10. Fresco C, Avanzini F, Bosi S, Franzosi MG, Maggioni AP, Santoro L, Bellanti G (1996) Prognostic value of a history of hypertension in 11, 483 patients with acute myocardial infarction treated with thrombolysis. GISSI-2 Investigators. Gruppo Italiano per lo Studio della, Sopravvivenza nell'Infarto Miocardico. J Hypertens 14:743-750
11. Aylward PE, Wilcox RG, Horgan JH, White HD, Granger CB, Califf RM, Topol EJ (1996) Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators. Ann Intern Med 125:891-900
12. Majahalme SK, Smith DE, Cooper JV, Kline-Rogers E, Mehta RH, Eagle KA, Bisognano JD (2003) Comparison of patients with acute coronary syndrome with and without systemic hypertension. Am J Cardiol 92:258-263 (Pubitemid 36897705)
13. Jonas M, Grossman E, Boyko V, Behar S, Hod H, Reicher-Reiss H (1999) Relation to early and one year outcome after acute myocardial infarction to systemic arterial blood pressure on admission. Am J Cardiol 84:162-165 (Pubitemid 29331332)
14. Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF (2010) Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. J Cardiovasc Med (Hagerstown) 11(1):7-13
15. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2011) Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience. Intern Emerg Med 6(1): 41-46
16. Valente S, Lazzeri C, Chiostri M, Sori A, Giglioli C, Gensini GF (2011) Prior and new onset anemia in ST-elevation myocardial infarction: a different prognostic role? Intern Emerg Med
17. Lazzeri C, Sori A, Chiostri M, Gensini GF, Valente S (2009) Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 26(10):856-862
18. Valente S, Lazzeri C, Chiostri M, Giglioli C, SoriA, Tigli S, Gensini GF (2009) NT-pro BNP on admission for early risk stratification in STEMI patients submitted toPCI. Relation with extension ofSTEMI and inflammatory markers. Int J Cardiol 132(1):84-89
19. Valente S, Lazzeri C, Saletti E, Chiostri M, Gensini GF (2008) Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence. J Cardiovasc Med (Hagerstown) 9(11):1083-1087
20. European Association for Percutaneous Cardiovascular Interventions, Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D; ESC Clinical Guidelines Committee, Kolh P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, Kearney P, von Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, NocM, Piek JJ, Pirk J, RozenmanY, SabateM, Starc R, Thielmann M, Wheatley DJ, Windecker S, Zembala M, Guidelines on myocardial revascularization (2010) The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31(20):2501-2555
21. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, ESC Committee for Practice Guidelines (CPG) (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29(23):2909-2945
22. Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF (2010) Prognostic values of admission transaminases in ST-elevation myocardial infarction submitted to primary angioplasty. Med Sci Monit 16(12):CR567-CR574
23. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-E PI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604-612
24. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P, American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117(12):1610-1619 (Pubitemid 351440650)
25. Balkau B, Charles M, for the European Group for the Study of Insulin Resistance (EGIR) (1999) Comment on the provisional report from the WHO Consultation. Diabet Med 16:442-443
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and eta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412-419 (Pubitemid 15018832)
27. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response. Diab Vasc Dis Res 7(2): 131-137
28. Rembek M, Goch A, Goch J (2010) The clinical course of acute ST-elevation myocardial infarction in patients with hypertension. Kardiol Pol 68:157-163
29. Dumaine R, Gibson CM, Murphy SA, Southard M, Ly HQ, McCabe CH, Giugliano RP, Cannon CP, Antman EM, Braunwald E (2006) Thrombolysis in Myocardial Infarction (TIMI) Study Group (2006) Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome. J Clin Hypertens 8:315-322
30. Pitsavos C, Kourlaba G, Panagiotakos DB, Stefanadis C, GREECS Study Investigators (2006) Factors associated with delay in seeking health care for hospitalized patients with acute coronary syndromes: the GREECS study. Hellenic J Cardiol 47: 329-336 (Pubitemid 47621118)
31. Abrignani MG, Dominguez LJ, Biondo G, Di Girolamo A, Novo G, Barbagallo M, Braschi A, Braschi G, Novo S (2005) In-hospital complications of acute myocardial infarction in hypertensive subjects. Am J Hypertens 18(2 Pt 1):165-170 (Pubitemid 40332544)
32. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2011) Correlates of acute insulin resistance in the early phase of nondiabetic ST-elevation myocardial infarction. Diab Vasc Dis Res 8(1):35-42